DRKS00024773招募中未知
A Trial investigating the Accuracy of Continuous Glucose Monitor systems (Supersapiens” Abbott Libre Sense and Dexcom G6) During Exercise in People with Normal Glucose Tolerance - SuperComEx
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Informed consent obtained
- •- Body mass index 18.0–29.9 kg/m2 (both inclusive)
- •- Normal glucose tolerance (measured via fasting blood glucose levels)
- •- Participants performing regular physical activity during the last 3 months prior to screening
- •- Mass-specific peak oxygen consumption (VO2peak) >20 ml/kg/min
排除标准
- •- Enrolment in other study
- •- Known or suspected hypersensitivity to trial product(s) or related products
- •- Receipt of any investigational medicinal product within 1 week prior to screening in this trial
- •- Suffer from or history of a life-threatening disease (i.e. cancer judged not to be in full remission except basal cell skin cancer or squamous cell skin cancer), or clinically severe diseases that directly influence the study results, as judged by the Investigator. This does not prohibit the participation of patients taking medications that influences the metabolism (e.g. statin) or cardio-respiratory system (e.g. asthma spray) as long as the therapy is stable and is not adapted throughout the run of the trial. Furthermore, it does not excluded patients how have celiac disease (or similar diseases or allergies), as long as the disease is stable, and patients are able to stay on their specific (e.g.) gluten-free diet.
- •- Participant with a heart rate <35 beats per minute (bpm) at screening (after resting for 5 min in supine position)
- •- Supine blood pressure at screening (after resting for 5 min in supine position) outside the range of 90-150 mmHg for systolic or 50-95 mmHg for diastolic (excluding white-coat hypertension; therefore, if a repeated measurement on a second screening Visit shows values within the range, the participant can be included in the trial). This exclusion criterion also pertains to participants being on anti-hypertensives
- •- Significant abnormal ECG at screening, as judged by the Investigator
- •- Any chronic (metabolic) disorder or severe disease which, in the opinion of the Investigator might jeopardise participant’s safety or compliance with the protocol
- •- History of multiple and/or severe allergies to drugs or foods or a history of severe anaphylactic reaction
- •- Participant with mental incapacity or language barriers precluding adequate understanding or cooperation or who, in the opinion of their general practitioner or the Investigator, should not participate in the trial
- •- Potentially non-compliant or uncooperative during the trial, as judged by the Investigator
- •- Any condition that would interfere with trial participation or evaluation of results, as judged by the Investigator
- •- Female of childbearing potential who is pregnant, breast-feeding or intend to become pregnant or is not using adequate contraceptive methods (adequate contraceptive measures include sterilisation, hormonal intrauterine devices, oral contraceptives, sexual abstinence or vasectomised partner).
研究者
相似试验
招募中
不适用
Efficacy of Grit Wellbeing program for individuals attending residential rehabilitation for substance use problems.ACTRN12617001451392niversity of Queensland90
招募中
Unknown
the effectiveness of the continuous care model in patients with bladder cancerIRCT20240221061076N1Shahid Beheshti University of Medical Sciences58
尚未招募
2 期
Effect of glargine insulin on hyperglycemic control in type II diabetic patientsIRCT20130428013159N11Mashhad University of Medical Sciences80
尚未招募
3 期
Effect of glargine insulin on hyperglycemic control in type II diabetic patientsIRCT20130428013159N12Mashhad University of Medical Sciences80
招募中
2 期
Effect of Gasro-Fix on children acute diarrheaCondition 1: gastroenteritis. Condition 2: gastroenteritis.Viral intestinal infection, unspecifiedOther viral enteritisIRCT2017091536195N1Vice Chancellor for research of Alborz University of Medical Sciences150